{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "57894-503",
      "generic_name": "daratumumab and hyaluronidase-fihj (human recombinant)",
      "labeler_name": "Janssen Biotech, Inc.",
      "brand_name": "Darzalex Faspro",
      "active_ingredients": [
        {
          "name": "DARATUMUMAB",
          "strength": "1800 mg/15mL"
        },
        {
          "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
          "strength": "30000 U/15mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "57894-503-01",
          "description": "1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01)  / 15 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20200501",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Janssen Biotech, Inc."
        ],
        "rxcui": [
          "2375136",
          "2375141"
        ],
        "spl_set_id": [
          "4bb241af-4299-4373-8762-2d6709515db0"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000192336",
          "N0000192335",
          "M0001357",
          "N0000175531",
          "M0009499"
        ],
        "pharm_class_epc": [
          "CD38-directed Cytolytic Antibody [EPC]",
          "Endoglycosidase [EPC]"
        ],
        "pharm_class_moa": [
          "CD38-directed Antibody Interactions [MoA]"
        ],
        "pharm_class_cs": [
          "Antibodies, Monoclonal [CS]",
          "Glycoside Hydrolases [CS]"
        ],
        "unii": [
          "4Z63YK6E0E",
          "743QUY4VD8"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION",
      "spl_id": "bf986b71-66e2-4883-9687-f340388abafe",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20200501",
      "product_id": "57894-503_bf986b71-66e2-4883-9687-f340388abafe",
      "application_number": "BLA761145",
      "brand_name_base": "Darzalex Faspro",
      "pharm_class": [
        "Antibodies",
        "Monoclonal [CS]",
        "CD38-directed Antibody Interactions [MoA]",
        "CD38-directed Cytolytic Antibody [EPC]",
        "Endoglycosidase [EPC]",
        "Glycoside Hydrolases [CS]"
      ]
    }
  ]
}